Investment Trusts

Worldwide Healthcare

WWH:LSE

Worldwide Healthcare

  • Price (GBX)334.00
  • Today's Change-2.50 / -0.74%
  • Shares traded883.97k
  • 1 Year change1.37%
  • Beta0.4137
Data delayed at least 20 minutes, as of Apr 25 2024 17:56 BST.
More ▼
Total returns on £1000
1Y
Fund/benchmarkChange
PriceWorldwide Healthcare (Ordinary Share)+5.60%
NAVWorldwide Healthcare (Ordinary Share)+5.80%
Morningstar's BenchmarkMSCI World Health Care GR--

Key statistics

Worldwide Healthcare (WWH:LSE) set a new 52-week high during Wednesday's trading session when it reached 336.50. Over this period, the share price is up 4.05%.
52-week range
Today
286.00Oct 31 2023336.50Apr 24 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding542.15m
Market cap1.82bn GBP
Total assets2.03bn GBP
Total expense ratio0.83%
High334.50
Low328.50
Previous close336.50
Average volume1.43m
YTD Change+7.40%
Beta0.4137
Diluted NAV (est)372.66
Diluted NAV (last pub)373.29
Premium/Discount-10.37%
Net Gearing+0.80%
Annual div (ADY)3.10 GBX
Annual div yield (ADY)0.92%
Div ex-dateNov 23 2023
Div pay-dateJan 11 2024
Data delayed at least 20 minutes, as of Apr 25 2024 17:56 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.